Who Supplies Guaifenesin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Guaifenesin exports, with 151+ registered manufacturers shipping to buyers across 77+ countries — yet a handful of companies dominate the shipments. GRANULES INDIA LIMITED holds the largest share at 28.3% (export value: $7.5M). Close behind, ELYSIUM PHARMACEUTICALS LTD (8.8%, $2.3M). SUN PHARMACEUTICAL INDUSTRIES LIMITED (3.3%, $869.1K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Guaifenesin? Top Manufacturers & Their Buyers
Flow of Guaifenesin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Guaifenesin Supplier Network — Key Market Intelligence
The Guaifenesin export market from India is led by GRANULES INDIA LIMITED, which alone commands a 28.3% share, shipping $7.5M worth of product across 181 shipments. The second-largest exporter, ELYSIUM PHARMACEUTICALS LTD, contributes $2.3M (8.8%) to the overall market. Combined, the top two suppliers alone account for 37.1% of all Guaifenesin exports, indicating a relatively concentrated supply base.
Across all 151 tracked manufacturers, the total Guaifenesin export value stands at $26.7M from 1.1K shipments. The market average shipment value is $25.4K. The single largest buyer relationship in terms of trade value is GRANULES CONSUMER HEALTH, LLC, receiving $5.4M worth of product.
The combined buyer network spans 16 named purchasing companies, including GRANULES CONSUMER HEALTH, LLC, GRANULES USA INC., PERRIGO COMPANY PLANT, PRODOSE INC., SHREE HARI INTERNATIONAL LLC and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1GRANULES INDIA LIMITED
GRANULES INDIA LIMITED is the first-largest Guaifenesin exporter from India, with a market share of 28.3% and a total export value of $7.5M across 181 shipments. Their average shipment value of $41.7K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
GRANULES INDIA LIMITED serves 5 named buyers in our database. GRANULES CONSUMER HEALTH, LLC is the dominant customer, accounting for 71.7% of this supplier's tracked business. Top customers include:
• GRANULES CONSUMER HEALTH, LLC — $5.4M across 130 shipments (71.7% of this supplier's total exports)
• GRANULES USA INC. — $727.4K across 17 shipments (9.6% of this supplier's total exports)
• GRANULES USA INC. — $643.6K across 15 shipments (8.5% of this supplier's total exports)
• PERRIGO COMPANY PLANT — $499.2K across 12 shipments (6.6% of this supplier's total exports)
• GRANULES CONSUMER HEALTH, LLC — $266.4K across 6 shipments (3.5% of this supplier's total exports)
Key Insight: GRANULES INDIA LIMITED's per-shipment value of $41.7K is 64% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
2ELYSIUM PHARMACEUTICALS LTD
ELYSIUM PHARMACEUTICALS LTD is the second-largest Guaifenesin exporter from India, with a market share of 8.8% and a total export value of $2.3M across 77 shipments. Their average shipment value of $30.4K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
ELYSIUM PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• PRODOSE INC. — $751.9K across 25 shipments (32.1% of this supplier's total exports)
• SHREE HARI INTERNATIONAL LLC — $632.0K across 21 shipments (27.0% of this supplier's total exports)
• SPIRIT PHARMACEUTICALS LLC, — $567.7K across 19 shipments (24.2% of this supplier's total exports)
• PRODOSE INC. — $220.1K across 7 shipments (9.4% of this supplier's total exports)
• SPIRIT PHARMACEUTICALS LLC, — $172.6K across 6 shipments (7.4% of this supplier's total exports)
Key Insight: ELYSIUM PHARMACEUTICALS LTD's per-shipment value of $30.4K is 20% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
3SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Guaifenesin exporter from India, with a market share of 3.3% and a total export value of $869.1K across 31 shipments. Their average shipment value of $28.0K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. OHM LABORATORIES INC. is the dominant customer, accounting for 59.2% of this supplier's tracked business. Top customers include:
• OHM LABORATORIES INC. — $514.1K across 18 shipments (59.2% of this supplier's total exports)
• OHM LABORATORIES INC. — $122.4K across 4 shipments (14.1% of this supplier's total exports)
• XXM LXXORAXXRIEXXINC — $101.0K across 4 shipments (11.6% of this supplier's total exports)
• MAA Laboratories Inc — $100.9K across 4 shipments (11.6% of this supplier's total exports)
• XXM LXXORAXXRIEXXINC — $30.7K across 1 shipments (3.5% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $28.0K is 10% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
4BRAWN LABORATORIES LIMITED
BRAWN LABORATORIES LIMITED is the fourth-largest Guaifenesin exporter from India, with a market share of 3.0% and a total export value of $793.2K across 24 shipments. Their average shipment value of $33.1K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
BRAWN LABORATORIES LIMITED serves 2 named buyers in our database. IBN SINA SCIENTIFIC BUREAU is the dominant customer, accounting for 95.7% of this supplier's tracked business. Top customers include:
• IBN SINA SCIENTIFIC BUREAU — $758.9K across 23 shipments (95.7% of this supplier's total exports)
• OMEGA CARE COMPANY — $34.3K across 1 shipments (4.3% of this supplier's total exports)
Key Insight: BRAWN LABORATORIES LIMITED's per-shipment value of $33.1K is 30% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
5AGIO PHARMACEUTICALS LIMITED
AGIO PHARMACEUTICALS LIMITED is the fifth-largest Guaifenesin exporter from India, with a market share of 2.5% and a total export value of $657.4K across 34 shipments. Their average shipment value of $19.3K is below the market average of $25.4K, reflecting a high-volume, competitive pricing strategy.
AGIO PHARMACEUTICALS LIMITED serves 4 named buyers in our database. AGIO RUS LLC is the dominant customer, accounting for 95.4% of this supplier's tracked business. Top customers include:
• AGIO RUS LLC — $627.0K across 32 shipments (95.4% of this supplier's total exports)
• NEMAN-FARM LLC — $16.9K across 1 shipments (2.6% of this supplier's total exports)
• AGIO HEALTHCARE INTE — $9.5K across 0 shipments (1.4% of this supplier's total exports)
• OOO E T C PHARMA — $3.9K across 0 shipments (0.6% of this supplier's total exports)
Key Insight: AGIO PHARMACEUTICALS LIMITED operates with high shipment frequency (34 shipments) at a per-shipment value of $19.3K, indicating a broad distribution network with many smaller, regular orders.
6LINCOLN PHARMACEUTICALS LTD
LINCOLN PHARMACEUTICALS LTD is the fifth-largest Guaifenesin exporter from India, with a market share of 2.4% and a total export value of $636.2K across 7 shipments. Their average shipment value of $90.9K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
LINCOLN PHARMACEUTICALS LTD serves 1 named buyer in our database. MAKANS LIMITED is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• MAKANS LIMITED — $636.2K across 7 shipments (100.0% of this supplier's total exports)
Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $90.9K is 257% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Guaifenesin Flows
Once Guaifenesin leaves the manufacturing plants of companies like GRANULES INDIA LIMITED and ELYSIUM PHARMACEUTICALS LTD, it travels to 5 destination markets with a combined import value of $26.7M. United States absorbs the largest share at 69.6% ($18.6M), followed by Iraq (3.4%) and Russia (3.2%).
In United States — the top destination — named importers include GRANULES CONSUMER HEALTH, SPIRIT PHARMACEUTICALS LLC, PERRIGO COMPANY. In Iraq, key buyers are IBN SINA SCIENTIFIC BUREAU.
This geographic spread reflects Guaifenesin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Guaifenesin Go? Top Importing Countries & Their Buyers
Trade flow of Guaifenesin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Guaifenesin imports from India, with a total trade value of $18.6M across 335 shipments — representing a 69.6% share of all Guaifenesin exports. The average shipment value of $55.5K is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 16 tracked buyers.
Named Guaifenesin importers in United States: GRANULES CONSUMER HEALTH is the largest buyer, accounting for 31.5% ($5.8M) of this market's total imports.
• GRANULES CONSUMER HEALTH — $5.8M (31.5% of United States's total)
• SPIRIT PHARMACEUTICALS LLC — $2.8M (14.9% of United States's total)
• PERRIGO COMPANY — $1.1M (6.2% of United States's total)
Key Insight: United States's per-shipment average of $55.5K (118% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Guaifenesin imports from India.
2Iraq
Iraq ranks as the second-largest destination for Guaifenesin imports from India, with a total trade value of $915.0K across 22 shipments — representing a 3.4% share of all Guaifenesin exports. The average shipment value of $41.6K is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Guaifenesin importers in Iraq: IBN SINA SCIENTIFIC BUREAU is the largest buyer, accounting for 82.9% ($758.9K) of this market's total imports.
• IBN SINA SCIENTIFIC BUREAU — $758.9K (82.9% of Iraq's total)
Key Insight: Iraq's per-shipment average of $41.6K (64% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Iraq is a key market for Guaifenesin imports from India.
3Russia
Russia ranks as the third-largest destination for Guaifenesin imports from India, with a total trade value of $841.3K across 33 shipments — representing a 3.2% share of all Guaifenesin exports. The average shipment value of $25.5K is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Guaifenesin importers in Russia: AGIO RUS LLC is the largest buyer, accounting for 99.5% ($837.4K) of this market's total imports.
• AGIO RUS LLC — $837.4K (99.5% of Russia's total)
Key Insight: Russia's per-shipment average of $25.5K (0% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Guaifenesin imports from India.
4Fiji
Fiji ranks as the fourth-largest destination for Guaifenesin imports from India, with a total trade value of $686.5K across 7 shipments — representing a 2.6% share of all Guaifenesin exports. The average shipment value of $98.1K is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Guaifenesin importers in Fiji: MAKANS LIMITED is the largest buyer, accounting for 95.7% ($656.9K) of this market's total imports.
• MAKANS LIMITED — $656.9K (95.7% of Fiji's total)
Key Insight: Fiji's per-shipment average of $98.1K (286% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Fiji is a key market for Guaifenesin imports from India.
5United Arab Emirates
United Arab Emirates ranks as the fifth-largest destination for Guaifenesin imports from India, with a total trade value of $429.7K across 0 shipments — representing a 1.6% share of all Guaifenesin exports. The average shipment value of $429.7K is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations.
Key Insight: United Arab Emirates's per-shipment average of $429.7K (1590% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Guaifenesin imports from India.
People Also Ask — Guaifenesin Supplier & Trade Network
Who are the top suppliers of Guaifenesin from India?+
Which companies buy Guaifenesin from Indian manufacturers?+
Where does Guaifenesin exported from India go?+
What is the market share of the top Guaifenesin supplier from India?+
What is the average shipment value for Guaifenesin exports from India?+
Is Guaifenesin manufactured in India and exported globally?+
Which country imports the most Guaifenesin from India?+
Who are the buyers of Guaifenesin in Iraq?+
How concentrated is the Guaifenesin supplier market in India?+
How do I find verified buyers for Guaifenesin in specific countries?+
Guaifenesin Trade Network — Key Takeaways
- 1GRANULES INDIA LIMITED is India's dominant Guaifenesin exporter with a 28.3% market share and $7.5M in total exports — making it the single most important sourcing entity in this market.
- 2The top 151 suppliers collectively account for 48.1% of all tracked Guaifenesin exports, with a combined trade value of $26.7M.
- 3United States is the largest destination market, absorbing 69.6% of India's Guaifenesin exports ($18.6M). Iraq (3.4%) and Russia (3.2%) follow.
- 4With 1.1K total shipments averaging $25.4K each, the Guaifenesin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include GRANULES CONSUMER HEALTH, LLC, GRANULES USA INC., PRODOSE INC., SHREE HARI INTERNATIONAL LLC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 77 countries
Network value: $26.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Guaifenesin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Guaifenesin.
- 2.Flow Mapping: 151 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,050 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 77 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,050 Verified Shipments
151 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists